Dark | Light
# Climb Bio, Inc (CLYM)

Climb Bio, Inc (CLYM) price surges to a 52-week high of $6, driven by significant social media attention and positive analyst ratings. Piper Sandler initiates coverage with an 'Overweight' rating and a $23 price target, highlighting budoprutug's potential.

### About Climb Bio, Inc
Climb Bio, Inc is a biotechnology company focused on developing novel therapeutics.  
Climb Bio, Inc uses the ticker $CLYM for trading. Listed in the [Stocks](/list/stocks) category.

### Insights
- Climb Bio, Inc (CLYM) mentions hit [---] which is 572% higher than it's daily average.
- Climb Bio, Inc (CLYM) creators hit [---] which is 376% higher than it's daily average.
- Climb Bio, Inc (CLYM) social dominance hit [------] which is 383% higher than it's daily average.
- Climb Bio, Inc (CLYM) market dominance near a 52-week high at [-------].
- Climb Bio, Inc (CLYM) trading volume is up 715.61% from the previous month.
- Climb Bio, Inc (CLYM) social dominance is up 8300% from the previous [--] months.
- Climb Bio, Inc (CLYM) posts created is up 41.86% from the previous week.
- Climb Bio, Inc Price hit a 52-Week high of $6 for the hour
- Climb Bio, Inc Price hit an all time of $6 for the hour

### Price: $5.70
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$clym/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$clym/time-series/close.tsv)  
The stock price has experienced a strong positive surge, hitting a 52-week high, strongly correlated with a significant increase in social dominance and engagements, suggesting heightened social media attention is a primary driver of this recent rally, further bolstered by positive analyst ratings.  

24-Hour: 7.21%
7-Day: 5.19%
30-Day: 34.36%

1-Year High: $5.80 on 2026-02-09  
1-Year Low: $1.20 on 2025-06-27  
  
  
### AltRank: [-----]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$clym/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$clym/time-series/alt_rank.tsv)  
Climb Bio, Inc (CLYM) is currently AltRank #1,328 based on combined combined social and market metrics
Daily Average: [-----]  
[--] Week: [-----] +1,126  
1-Year High: [-----] on 2026-02-03  
1-Year Low: [---] on 2026-01-25  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$clym/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$clym/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] [---]  
[--] Month: [--] +23  
[--] Months: [--] [---]  
[--] Year: [--] +18  
1-Year High: [--] on 2026-02-13  
1-Year Low: [--] on 2025-10-14  
  
  
### Engagements: [-----] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$clym/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$clym/time-series/interactions.tsv)  
Current Value: [-----]  
Daily Average: [-----]  
[--] Week: [------] -38%  
[--] Month: [-------] -34%  
[--] Months: [-------] +168%  
[--] Year: [-------] +297%  
1-Year High: [------] on 2025-12-12  
1-Year Low: [--] on 2025-09-25  

Engagements by network (24h):
YouTube: [--]
News: [--]
Reddit: [---]
X: [-----]

  
  
### Mentions: [---] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$clym/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$clym/time-series/posts_active.tsv)  
Current Value: [---]  
Daily Average: [--]  
[--] Week: [---] -26%  
[--] Month: [---] +2,705%  
1-Year High: [---] on 2025-10-20  
1-Year Low: [--] on 2025-03-05  

Mentions by network (24h):
YouTube: [--]
News: [--]
Reddit: [--]
X: [---]

  
  
### Creators: [---] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$clym/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$clym/time-series/contributors_active.tsv)  
[---] unique social accounts have posts mentioning Climb Bio, Inc (CLYM) in the last [--] hours which is up 85% from [--] in the previous [--] hours
Daily Average: [--]  
[--] Week: [---] +4.50%  
[--] Month: [---] +932%  
1-Year High: [---] on 2025-06-29  
1-Year Low: [--] on 2025-02-17  

The most influential creators that mention Climb Bio, Inc in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@Brad_E_Schulz](/creator/twitter/Brad_E_Schulz)     | [--]    | [------]    | [--]     | [---]         |
| [@Quantumup1](/creator/twitter/Quantumup1)           | [--]    | [-----]     | [--]     | [---]         |
| [@MarcJacksonLA](/creator/twitter/MarcJacksonLA)     | [--]    | [-----]     | [--]     | [---]         |
| [@Sjobba123](/creator/twitter/Sjobba123)             | [--]    | [---]       | [--]     | [---]         |
| [@stevenplace](/creator/twitter/stevenplace)         | [--]    | [-----]     | [--]     | [---]         |
| [@IJesusChrist](/creator/reddit/IJesusChrist)        | [--]    | [------]    | [--]     | [---]         |
| [@WrightWhit84274](/creator/twitter/WrightWhit84274) | [--]    | [--]        | [--]    | [--]          |
| [@_Etere_](/creator/twitter/_Etere_)                 | [--]    | [--]        | [--]     | [--]          |
| [@Esra_Ayhan2010](/creator/twitter/Esra_Ayhan2010)   | [--]    | [---]       | [--]     | [--]          |
| [@A_May_MD](/creator/twitter/A_May_MD)               | [--]   | [------]    | [--]     | [--]          |

[View More](/list/creators/$clym/100)
  
  
### Sentiment: 82%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$clym/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$clym/time-series/sentiment.tsv)  
Current Value: 82%  
Daily Average: 91%  
[--] Week: 67% -19%  
[--] Month: 65% -35%  
[--] Months: 65% -35%  
[--] Year: 65% -35%  
1-Year High: 100% on 2025-02-18  
1-Year Low: 33% on 2025-10-07  

Most Supportive Themes:
- Bio/Pharm Sector Performance: (75%) Climb Bio, Inc is mentioned within a broader discussion of the Bio/Pharm sector's positive performance.
- General Market Watchlist: (25%) Climb Bio, Inc is included in a general watchlist of stocks for the day, indicating broader market interest.
  
Most Critical Themes:
  
  
  
### Social Dominance: 0.012%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$clym/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$clym/time-series/social_dominance.tsv)  
Current Value: 0.012%  
Daily Average: 0.00348%  
[--] Week: 0.0082% +0.0025%  
[--] Month: 0.017% +0.014%  
[--] Months: 0.017% +0.013%  
[--] Year: 0.017% +0.017%  
1-Year High: 0.028% on 2026-01-25  
1-Year Low: 0.0001% on 2025-09-25  
  
  
### Market Dominance: 0.00043781535741617064%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$clym/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$clym/time-series/market_dominance.tsv)  
Current Value: 0.00043781535741617064%  
Daily Average: 0%  
1-Year High: 0.00045% on 2026-02-09  
1-Year Low: 0.0003% on 2026-01-15  
  
  
### Market Cap: $386,605,746
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$clym/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$clym/time-series/market_cap.tsv)  
Current Value: $386,605,746  
Daily Average: $330,384,581  
[--] Week: $385,242,058 +4.80%  
[--] Month: $386,605,746 +50%  
1-Year High: $393,424,190 on 2026-02-09  
1-Year Low: $257,055,320 on 2026-01-15  

### Top Climb Bio, Inc Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"Fails of the week. Sold $clym before rally. Bought $ibrx on breakout which stopped out. Fsly still working for me though"  
[X Link](https://x.com/Sjobba123/status/2022575219454459982) [@Sjobba123](/creator/x/Sjobba123) 2026-02-14T07:34Z [---] followers, [---] engagements


"$CL -Rothschild Redburn raise Colgate-Palmolive target to $93 from $84 Neutral $CLMT -UBS raises Calumet target to $26 from $13.25 Neutral $CLYM -Piper Sandler initiates Climb Bio coverage at Overweight highlighting budoprutug potential Sets $23 target https://au.investing.com/news/analyst-ratings/piper-sandler-initiates-climb-bio-stock-with-overweight-rating-23-target-93CH-4258451 https://au.investing.com/news/analyst-ratings/piper-sandler-initiates-climb-bio-stock-with-overweight-rating-23-target-93CH-4258451"  
[X Link](https://x.com/MarcJacksonLA/status/2022407730146029744) [@MarcJacksonLA](/creator/x/MarcJacksonLA) 2026-02-13T20:29Z [----] followers, [---] engagements


"$CLYM [--] break today Piper Sandler $23 pt Piper Sandler initiated coverage of Climb Bio with an Overweight rating and $23 price target. The company is developing budoprutug across three indications and CLYM116 in Berger's disease the analyst tells investors in a research note. Piper says Climb Bio has "multiple shots on goal to unlock significant value" heading into a catalyst-rich [----]. $CLYM https://t.co/tA7WEIF67w $CLYM https://t.co/tA7WEIF67w"  
[X Link](https://x.com/zohmbastic/status/2022372262457057571) [@zohmbastic](/creator/x/zohmbastic) 2026-02-13T18:08Z 10.1K followers, [----] engagements


"Notable [--] Week Highs $ADAG $ADNT $AEE $AEP $AER $AHR $AKAM $AL $AM $AAT $ANAB $AQN $ASC $ATMU $AVA $AVO $AZN $BAYA $BG $BLX $BRC $BRX $BZH $CCO $CCS $CECO $CLMT $CLYM $CMS $CNP $COP $CPS $CTOS $CTRE $CWEN $D $DAR $DBD $DOCN $DTE $ECG $EE $EIX $ENB $EPD $ERAS Part [--] Cont. -"  
[X Link](https://x.com/MarcJacksonLA/status/2022361956389429626) [@MarcJacksonLA](/creator/x/MarcJacksonLA) 2026-02-13T17:27Z [----] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

Climb Bio, Inc (CLYM)

Climb Bio, Inc (CLYM) price surges to a 52-week high of $6, driven by significant social media attention and positive analyst ratings. Piper Sandler initiates coverage with an 'Overweight' rating and a $23 price target, highlighting budoprutug's potential.

About Climb Bio, Inc

Climb Bio, Inc is a biotechnology company focused on developing novel therapeutics.
Climb Bio, Inc uses the ticker $CLYM for trading. Listed in the Stocks category.

Insights

  • Climb Bio, Inc (CLYM) mentions hit [---] which is 572% higher than it's daily average.
  • Climb Bio, Inc (CLYM) creators hit [---] which is 376% higher than it's daily average.
  • Climb Bio, Inc (CLYM) social dominance hit [------] which is 383% higher than it's daily average.
  • Climb Bio, Inc (CLYM) market dominance near a 52-week high at [-------].
  • Climb Bio, Inc (CLYM) trading volume is up 715.61% from the previous month.
  • Climb Bio, Inc (CLYM) social dominance is up 8300% from the previous [--] months.
  • Climb Bio, Inc (CLYM) posts created is up 41.86% from the previous week.
  • Climb Bio, Inc Price hit a 52-Week high of $6 for the hour
  • Climb Bio, Inc Price hit an all time of $6 for the hour

Price: $5.70

Price Line Chart
Price 24-Hour Time-Series Raw Data
The stock price has experienced a strong positive surge, hitting a 52-week high, strongly correlated with a significant increase in social dominance and engagements, suggesting heightened social media attention is a primary driver of this recent rally, further bolstered by positive analyst ratings.

24-Hour: 7.21% 7-Day: 5.19% 30-Day: 34.36%

1-Year High: $5.80 on 2026-02-09
1-Year Low: $1.20 on 2025-06-27

AltRank: [-----]

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Climb Bio, Inc (CLYM) is currently AltRank #1,328 based on combined combined social and market metrics Daily Average: [-----]
[--] Week: [-----] +1,126
1-Year High: [-----] on 2026-02-03
1-Year Low: [---] on 2026-01-25

Galaxy Score: [-----]

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] +23
[--] Months: [--] [---]
[--] Year: [--] +18
1-Year High: [--] on 2026-02-13
1-Year Low: [--] on 2025-10-14

Engagements: [-----] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [-----]
[--] Week: [------] -38%
[--] Month: [-------] -34%
[--] Months: [-------] +168%
[--] Year: [-------] +297%
1-Year High: [------] on 2025-12-12
1-Year Low: [--] on 2025-09-25

Engagements by network (24h): YouTube: [--] News: [--] Reddit: [---] X: [-----]

Mentions: [---] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [--]
[--] Week: [---] -26%
[--] Month: [---] +2,705%
1-Year High: [---] on 2025-10-20
1-Year Low: [--] on 2025-03-05

Mentions by network (24h): YouTube: [--] News: [--] Reddit: [--] X: [---]

Creators: [---] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[---] unique social accounts have posts mentioning Climb Bio, Inc (CLYM) in the last [--] hours which is up 85% from [--] in the previous [--] hours Daily Average: [--]
[--] Week: [---] +4.50%
[--] Month: [---] +932%
1-Year High: [---] on 2025-06-29
1-Year Low: [--] on 2025-02-17

The most influential creators that mention Climb Bio, Inc in the last [--] hours

Creator Rank Followers Posts Engagements
@Brad_E_Schulz [--] [------] [--] [---]
@Quantumup1 [--] [-----] [--] [---]
@MarcJacksonLA [--] [-----] [--] [---]
@Sjobba123 [--] [---] [--] [---]
@stevenplace [--] [-----] [--] [---]
@IJesusChrist [--] [------] [--] [---]
@WrightWhit84274 [--] [--] [--] [--]
@Etere [--] [--] [--] [--]
@Esra_Ayhan2010 [--] [---] [--] [--]
@A_May_MD [--] [------] [--] [--]

View More

Sentiment: 82%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 82%
Daily Average: 91%
[--] Week: 67% -19%
[--] Month: 65% -35%
[--] Months: 65% -35%
[--] Year: 65% -35%
1-Year High: 100% on 2025-02-18
1-Year Low: 33% on 2025-10-07

Most Supportive Themes:

  • Bio/Pharm Sector Performance: (75%) Climb Bio, Inc is mentioned within a broader discussion of the Bio/Pharm sector's positive performance.
  • General Market Watchlist: (25%) Climb Bio, Inc is included in a general watchlist of stocks for the day, indicating broader market interest.

Most Critical Themes:

Social Dominance: 0.012%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.012%
Daily Average: 0.00348%
[--] Week: 0.0082% +0.0025%
[--] Month: 0.017% +0.014%
[--] Months: 0.017% +0.013%
[--] Year: 0.017% +0.017%
1-Year High: 0.028% on 2026-01-25
1-Year Low: 0.0001% on 2025-09-25

Market Dominance: 0.00043781535741617064%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00043781535741617064%
Daily Average: 0%
1-Year High: 0.00045% on 2026-02-09
1-Year Low: 0.0003% on 2026-01-15

Market Cap: $386,605,746

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $386,605,746
Daily Average: $330,384,581
[--] Week: $385,242,058 +4.80%
[--] Month: $386,605,746 +50%
1-Year High: $393,424,190 on 2026-02-09
1-Year Low: $257,055,320 on 2026-01-15

Top Climb Bio, Inc Social Posts

Top posts by engagements in the last [--] hours

Showing a maximum of [--] top social posts without a LunarCrush subscription.

"Fails of the week. Sold $clym before rally. Bought $ibrx on breakout which stopped out. Fsly still working for me though"
X Link @Sjobba123 2026-02-14T07:34Z [---] followers, [---] engagements

"$CL -Rothschild Redburn raise Colgate-Palmolive target to $93 from $84 Neutral $CLMT -UBS raises Calumet target to $26 from $13.25 Neutral $CLYM -Piper Sandler initiates Climb Bio coverage at Overweight highlighting budoprutug potential Sets $23 target https://au.investing.com/news/analyst-ratings/piper-sandler-initiates-climb-bio-stock-with-overweight-rating-23-target-93CH-4258451 https://au.investing.com/news/analyst-ratings/piper-sandler-initiates-climb-bio-stock-with-overweight-rating-23-target-93CH-4258451"
X Link @MarcJacksonLA 2026-02-13T20:29Z [----] followers, [---] engagements

"$CLYM [--] break today Piper Sandler $23 pt Piper Sandler initiated coverage of Climb Bio with an Overweight rating and $23 price target. The company is developing budoprutug across three indications and CLYM116 in Berger's disease the analyst tells investors in a research note. Piper says Climb Bio has "multiple shots on goal to unlock significant value" heading into a catalyst-rich [----]. $CLYM https://t.co/tA7WEIF67w $CLYM https://t.co/tA7WEIF67w"
X Link @zohmbastic 2026-02-13T18:08Z 10.1K followers, [----] engagements

"Notable [--] Week Highs $ADAG $ADNT $AEE $AEP $AER $AHR $AKAM $AL $AM $AAT $ANAB $AQN $ASC $ATMU $AVA $AVO $AZN $BAYA $BG $BLX $BRC $BRX $BZH $CCO $CCS $CECO $CLMT $CLYM $CMS $CNP $COP $CPS $CTOS $CTRE $CWEN $D $DAR $DBD $DOCN $DTE $ECG $EE $EIX $ENB $EPD $ERAS Part [--] Cont. -"
X Link @MarcJacksonLA 2026-02-13T17:27Z [----] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

Climb Bio, Inc (CLYM)
/topic/$clym